Target intelligence / Profile preview

Helicobacter pylori gamma-glutamyl transpeptidase (H. pylori GGT)

Target
H. pylori GGT
Molecular classification
Enzyme, Threonine N-terminal nucleophile (Ntn) hydrolase, Bacterial virulence factor
01

Overview

Helicobacter pylori gamma-glutamyl transpeptidase is a bacterial enzyme, classified as an N-terminal nucleophile (Ntn) hydrolase, essential for Helicobacter pylori colonization and virulence in the human stomach[1][4][5]. This enzyme catalyzes the hydrolysis and transpeptidation of γ-glutamyl bonds in substrates such as glutathione and glutamine, producing glutamate and ammonia, which can help neutralize gastric acid and modulate the host environment for bacterial survival[1][4][5]. H. pylori GGT is produced as a proenzyme and autocatalytically cleaved to form an active heterodimer with a large and small subunit, with the active site located in the small subunit[1][4][5]. The enzyme acts both extracellularly (secreted or periplasmic form) and plays a role in immune evasion, nutrient acquisition, and possibly gastric pathology associated with H. pylori infection[1][5]. Inhibition of H. pylori GGT is an experimental anti-virulence strategy under consideration for therapeutic development.

Other names
H. pylori GGTγ-glutamyl transpeptidase (bacterial)Gamma-glutamyltranspeptidase
02

Mechanism of action

Enzyme inhibitors (e.g., acivicin) block γ-glutamyl bond hydrolysis, inhibiting GGT's catalytic function[3] Potential immunomodulation, as GGT affects glutathione metabolism and ammonia production

03

Biological functions

Hydrolysis of γ-glutamyl bonds in compounds such as glutathione and glutamineTranspeptidation: transfers γ-glutamyl residues to other amino acids and peptidesGeneration of glutamate and ammoniaModulation of host immune responseContribution to nutrient metabolism and survival of Helicobacter pylori in the gastric environment
04

Disease associations

InfectionGastric inflammationPeptic ulcer diseaseGastric cancer risk factor
05

Safety considerations

Targeting GGT may affect human GGTs due to sequence conservation (~25% identity with mammalian GGT), raising potential for off-target effects[1][5]Bacterial resistance could develop to enzyme inhibitorsInterference with glutathione metabolism could have off-target physiological effects
06

Interacting drugs

Acivicin (inhibitor of GGT activity in bacterial studies)[3]

1 more in the full profile.

07

Biomarkers

GGT enzyme activity (detectable in H. pylori cultures or infected gastric tissue as a marker of bacterial colonization and virulence)[1]Not widely validated for patient selection or therapeutic monitoring

Beyond the preview

Go deeper on Helicobacter pylori gamma-glutamyl transpeptidase (H. pylori GGT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori gamma-glutamyl transpeptidase (H. pylori GGT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call